haylaavo

AGLSL

AGLSL · NSE · inactive
49.45
-1.65 (-3.23%)
as of 23 Oct 2019 close
Open
54.95
High
54.95
Low
47.20
Prev close
51.10
52w high
81.50
12 Nov 2018
52w low
43.00
06 Aug 2019
VWAP
50.38
Delivery %
34.7%
of volume
Volume 5,489 · turnover ₹2.77 L · NSE bhavcopy (official close) · history since 20 Jul 2017
Series
EQ
F&O
No
Status
Inactive since 02 Apr 2019

Source: NSE equity master · as of 01 Apr 2019

Daily · NSE EOD
Exchange announcements
Source: NSE corporate filings · latest Today 20:24 IST
  • 17 Oct 2019 15:03
    Exchange query

    AGLSL: Members of the Exchange are hereby informed that the trading in Equity Shares of Artemis Global Life Sciences Limited shall be suspended w.e.f. October 24, 2019 (i.e. closing hours of trading on October 23, 2019) on account of Scheme of Amalgamation of Artemis Global Life Sciences Limited with Artemis Medicare Services Limited

  • 18 Aug 2017 19:29
    Exchange query

    AGLSL:The Exchange had sought clarification from Artemis Global Life Sciences Limited with respect to announcement dated 04-Aug-2017, regarding Outcome of Board Meeting held on August 04, 2017. Appointment of Ms. Devlina Chakravarty as Managing Director and Mr. US Anand, Independent Director.". On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment);2. Disclosure of relationships between directors (in case of appointment of a director).The response of the Company is attached.

    PDF · -
  • 04 Aug 2017 20:10
    Exchange query

    AGLSL:The Exchange has sought clarification from Artemis Global Life Sciences Limited with respect to announcement dated 04-Aug-2017, regarding Outcome of Board Meeting held on August 04, 2017. Appointment of Ms. Devlina Chakravarty as Managing Director and Mr. US Anand, Independent Director.". On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment);2. Disclosure of relationships between directors (in case of appointment of a director).The response of the Company is awaited.

Coming next in news
Arrives in Phase 3. Nothing here is estimated or filled in — we only show data we have.
  • Results & board-meeting calendar
  • Dividend, split, AGM calendar
  • Headlines with source and timestamp
  • Two-line factual filing summaries